STI

Solidion Technology Inc. (STI) - Q1 2026 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended March 31, 2026. Solidion Technology Inc. is an advanced battery technology company focused on silicon anode materials, solid-state batteries, and energy storage solutions. The company operates as a smaller reporting company and an emerging growth company. It is currently in a development phase with minimal commercial revenue, relying on R&D and strategic partnerships.

Key Financial Metrics

Debt and Liquidity: Short-term notes payable totaled $2.61 million. The company is in default on a $2.2 million promissory note to EF Hutton LLC due to non-payment of scheduled installments. Cash burn remains a critical concern with only $38,887 in cash on hand.

Material Changes vs. Prior Period

• Revenue Recognition: The company recorded $85,426 in net sales for Q1 2026, compared to zero in Q1 2025, marking the beginning of commercial activity.
• Net Income Volatility: Q1 2025 reported a net income of $9.2 million driven almost entirely by a $12.4 million non-cash gain from the change in fair value of derivative liabilities. In Q1 2026, this gain decreased to $561,350, resulting in a net loss of $1.4 million.
• Operating Expenses: Total operating expenses decreased by approximately $1.27 million to $1.86 million, driven by reductions in R&D and SG&A costs.
• Cash Position: Cash reserves declined significantly from $204,725 at year-end 2025 to $38,887 at March 31, 2026.

Outlook, Risks, and Contingencies

• Going Concern: Management has raised substantial doubt about the company's ability to continue as a going concern. The company projects insufficient liquidity to sustain operations for the next 12 months without additional financing.
• Debt Default: The company is currently in default on a promissory note to EF Hutton LLC, which is accruing interest at a default rate of 24% per annum.
• Nasdaq Compliance: The company is not in compliance with Nasdaq Listing Rule 5605(c)(2)(A) regarding the composition of the Audit Committee (requires three independent directors; currently has two). A cure period extends until the annual meeting scheduled for June 11, 2026.
• Contingent Liabilities: A federal tax lien of approximately $2.2 million exists against the company's predecessor (G3), which could impact proceeds from the sale of company property. Additionally, 4,000 "Holdback Shares" remain unissued pending the resolution of this lien.
• Internal Controls: The company disclosed material weaknesses in internal controls over financial reporting, including insufficient segregation of duties and lack of qualified technical accounting personnel.
• Recent Developments: The company received three U.S. government grants (DOE and Army) for R&D and entered a non-binding MOU for potential $4-6 million in revenue over the next 12 months.

Investor Verification Checklist

• Liquidity Runway: Verify the status of the expired underwriting arrangement and the likelihood of securing new equity or debt financing given the $38,887 cash balance.
• Debt Resolution: Confirm the status of negotiations to amend the defaulted EF Hutton promissory note and the potential for acceleration of debt.
• Nasdaq Status: Monitor the appointment of a new independent director to the Audit Committee to avoid delisting.
• Derivative Liabilities: Review the valuation assumptions for the Forward Purchase Agreement and Series A warrants, which significantly impact reported earnings.
• Government Grants: Assess the probability of converting the non-binding MOU and government grants into actual revenue to offset operating losses.